United Therapeutics buy Royal Bank of Canada
Start price
26.09.25
/
50%
€364.40
Target price
26.09.26
€487.63
Performance (%)
12.95%
Price
18:20
€411.60
Summary
This prediction is currently active. The prediction currently has a performance of 12.95%. This prediction currently runs until 26.09.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 0.490% | 0.490% |
| iShares Core DAX® | 1.659% | 1.586% |
| iShares Nasdaq 100 | 0.381% | 1.900% |
| iShares Nikkei 225® | 2.102% | -1.377% |
| iShares S&P 500 | 0.221% | 1.258% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $569.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat